nnate lymphoid cells (ILCs) are functionally similar to T cells, but lack somatically recombined antigen receptors. Both early T cell progenitors and ILC progenitors depend on the expression of transcription factors such as T cell factor 1 (TCF-1; encoded by Tcf7), which might program similar functions in T cells and ILCs during development [1] [2] [3] [4] . Transcription factors specific for early ILCs, such as nuclear factor, interleukin 3 regulated (NFIL3), could imprint the innate features of ILCs. Understanding how these factors act to program the immune effector functions of ILCs requires the identification of the progenitor cells in which they act, and the developmental transitions they control. Early innate lymphoid progenitors (EILPs) are the earliest known specified ILC progenitors 1,4 . Unlike later ILC progenitors, EILPs are thought to contain uncommitted ILC progenitors that can also access the dendritic cell (DC) fate 1, 4 . Here, we use population-level and single-cell approaches to assess the transcriptional and functional heterogeneity within bone marrow (BM) ILC progenitors. We identified two successive stages of development within EILPs. Precursor cells at the earlier stage were specified to the ILC lineage, but expressed transcription factors important for DC development, and accessed the DC fate at steady state in vivo. Precursor cells at the later stage lacked expression of these factors, as well as DC potential, and were committed to the ILC lineage. At this newly characterized developmental bifurcation, we identified key roles for the transcription factor TCF-1 in promoting the developmental progression of ILC progenitors and enforcing their commitment to the ILC lineage. Our observations revealed a degree of imprecision during ILC specification before commitment, underscoring the complexity of fate transitions in hematopoiesis.
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Results
EILPs are transcriptionally heterogeneous. We performed single-cell RNA sequencing (scRNA-Seq) on Ly-6D 
IL-7Rα
+ all-lymphoid progenitors (ALPs), which are upstream of ILC progenitors and are Tcf7-GFP − (Fig. 1a ,b) 1 . After clustering, ALPs formed one cluster (cluster 1), whereas Tcf7-GFP + cells comprised five clusters (clusters 2-6; Fig. 1c ), which we identified on the basis of the expression of key transcription factors 1, 4, 8 . , were putative EILP clusters (Fig. 1c,d ). Consistently, clusters 2, 3 and 6 had very low expression of the cytokine receptor Il7r compared with all other ILC progenitor cells 1, 4, 8 . Next, we examined the developmental relationship between clusters using pseudotime reconstruction (Fig. 1e ) 9 . A main developmental progression linked ALPs, EILPs, ILCPs and ILC2Ps (clusters 1−5; Fig. 1e ). Analysis of differentially expressed transcription factors between clusters showed progressive upregulation or downregulation of factors such as Irf8, Spi1, Tcf7 or Tox along the pseudotime (Fig. 1f) . In an alternative developmental progression, cluster 6 EILPs arose from cluster 2 EILPs (Fig. 1e ). Cluster 6 EILPs had high expression of the transcription factors Batf3, Irf8, Spi1, Nfil3 and Id2 (Fig. 1f) , which are associated with conventional type 1 DC (cDC1) development 10 , as well as the DC structural gene Cd74 and major histocompatibility complex class II (MHC-II) molecules ( Fig. 1f and Supplementary Table 1 ). Cluster 6 EILPs appeared transcriptionally similar to cDC1-committed pre-cDC1 (refs. 11,12 ), although these cDC1 progenitors are CD11c + and were excluded by the Lin ILC cocktail. Zbtb46, which is upregulated on committed cDC BM precursors 11, 12 , was not detectably expressed in cluster 6 EILPs (Supplementary Table 1 ), suggesting that these cells represent an early stage of cDC1 priming. ILC-specific transcription factors, such as Tox, Tcf7 and Runx3, which are expressed in EILPs, have no described function in DCs and are not expressed in DC progenitors 13 , were detectable in cluster 6 (Fig. 1f) , and their expression was downregulated along the pseudotemporal progression (Fig. 1f) . On the basis of these results, we designated cluster 2 and cluster 6 as specified EILPs (sEILPs), comprising sEILP1s (cluster 2) and sEILP2s (cluster 6). sEILP1s and sEILP2s highly expressed the cDC genes Flt3, Irf8, Nfil3 and Spi1. Cluster 3 EILPs, which had downregulated the expression of Flt3, Irf8, Nfil3 and Spi1 (Fig. 1f) , were designated as committed EILPs (cEILPs). Our analysis placed sEILP1s at a branch point between the ILC and cDC1 lineages, indicating that ILC progenitors might access cDC1 lineage fate in vivo (Fig. 1g) .
sEILPs, but not cEILPs, have DC lineage potential. Next, we characterized the DC potential of EILPs. After 7 d of culture in the presence of OP9 stromal cells and the cytokines stem cell factor, Flt3L and interleukin-7 (IL-7) (hereafter, SF7 conditions), together with granulocyte-macrophage colony-stimulating factor and IL-3, which support DC survival and expansion (hereafter, SF7-GM3 conditions), Lin (Fig. 2c) , suggesting that cDCs develop from EILPs.
To quantify the frequency of DC-competent precursors within EILPs, we sorted single EILPs on OP9 cells in 96-well plates and cultured them for 10 d under SF7-GM3 conditions, or with the additional cytokines macrophage colony-stimulating factor, granulocyte colony-stimulating factor and IL-6, which promote the differentiation of early T cell precursors into myeloid cells and DCs (hereafter, SF7-GM3-MG6 conditions) 15 . Under both sets of conditions,
CD45
+ EILP-derived colonies contained Mac-1 (Fig. 2d) . Mac-1 − cells were ILC lineage cells ( Supplementary  Fig. 2a-c) 1, 7 . In the SF7-GM3-MG6 cultures, >50% of CD45 + wells contained only Mac-1 + DCs, ~40% contained only Mac-1 − ILCs, and <5% contained both ILCs and DCs (Fig. 2d,e) . The frequency of Mac-1 + colonies was decreased under SF7-GM3 conditions compared with SF7-GM3-MG6 conditions, but the size of these colonies was comparable under both conditions ( Fig. 2e and Supplementary  Fig. 2d ), suggesting that MG6 cytokines affected the survival of some EILPs. Furthermore, >50% of DC-competent EILPs gave rise to both CD24 hi cDC1 and CD172a hi cDC2 under SF7-GM3-MG6 and SF7-GM3 conditions ( Supplementary Fig. 2e ,f) 11, 12 . Together, these results indicate that a large fraction of EILPs possessed DC potential. However, 40% of EILPs exclusively generated ILCs.
Next, we examined whether transcriptional heterogeneity identified by scRNA-Seq in EILPs correlated with heterogeneity identified in differentiation assays. (Fig. 2f) . Using Flt3 and Zbtb16-GFP, we defined gates that matched the EILP fate (Fig. 2f) . These gates identified a Flt3 lo Zbtb16-GFP hi population that gave rise almost exclusively to Mac-1 − ILCs under SF7-GM3 and SF7-GM3-MG6 conditions (Fig. 2g,h) , and a Flt3 hi Zbtb16-GFP lo subset that predominantly gave rise to Mac-1 + DCs under SF7-GM3-MG6 conditions, but predominantly gave rise to ILC under SF7-GM3 conditions (Fig. 2g,h Fig. 4a ) indicated that they were transcriptionally similar to sEILPs and cEILPs, respectively (Fig. 3a) . We examined expression of the transcription factors GATA binding protein 3 (GATA-3), thymocyte selection-associated high mobility group box (TOX), NFIL3, purine-rich biding protein PU.1 and interferon regulatory factor 8 (IRF-8) in Flt3 hi PLZF lo sEILPs and Flt3 lo PLZF hi cEILPs. Consistent with the bulk RNA-Seq and scRNA-Seq, GATA-3 expression was upregulated from sEILPs to cEILPs; TOX expression was high in sEILPs and cEILPs; and PU.1 (encoded by Spi1), IRF-8 and NFIL3 expression was downregulated from sEILPs to cEILPs (Fig. 3b) 
Zbtb16-GFP
hi EILP populations correspond, respectively, to the sEILP and cEILP populations identified by scRNA-Seq. Supplementary Fig. 2 ) were more abundant in sEILP-derived colonies (70%) than cEILPderived colonies (50%; Supplementary Fig. 4b ), suggesting that sEILPs were more immature than cEILPs. ILC progeny (Tcf7 Supplementary Fig. 4c ). However, sEILP-derived ILC colonies were larger than cEILP-derived ILC colonies (Fig. 3c) . Furthermore, sEILPs were larger than cEILPs ( Supplementary Fig. 4d ), and contained a greater fraction of cycling cells (27% of DAPI hi sEILPs versus 5% of Supplementary Fig. 4f ). Most cEILP-derived cells were Tcf7-YFP
+

Zbtb16-GFP
+
Thy1
+ ILCPs, and had higher expression of Thy1 than sEILP-derived ILCPs (Fig. 3d) . To establish that sEILP-derived cEILPs were similar to ex vivo cEILPs, we isolated Tcf7-YFP sEILPs develop into cDC1 precursors in vivo. Using scRNASeq, we identified Nrp1 as encoding a surface marker that could resolve sEILP1s and sEILP2s (Fig. 1f) . Neuropilin-1 (NRP-1) was homogeneously expressed by Lin
int/lo pre-DCs (Fig. 4a) , as well as a fraction of sEILPs that corresponded to sEILP2s (Fig. 4a) . C-C chemokine receptor type 2 (CCR2) and MHC-II 11, 12 , which were upregulated from sEILP1 to sEILP2 at the RNA level (Fig. 1f) , were upregulated on NRP-1 + sEILP2s compared with NRP-1 − sEILP1s (Fig. 4b) . Expression of Tcf7-YFP, PLZF and IRF-8 on NRP-1 + sEILP2s was intermediate between NRP-1 − sEILP1s and pre-DCs, whereas TOX expression was similar on NRP-1 − sEILP1s and NRP-1 + sEILP2s ( Supplementary Fig. 4g,h ).
To determine whether sEILP1s and sEILP2s represented two successive stages of development towards DCs, we isolated Flt3 Supplementary Fig. 4i ), consistent with DC differentiation. Conversely, 82% of sEILP2 progeny were NRP-1 + and were mostly DCs ( Fig. 4c and Supplementary Fig. 4i ). More Tcf7 − sEILP2 progeny expressed Mac-1, MHC-II and CD11c compared with Tcf7 − sEILP1 progeny, and at higher levels ( Fig. 4c and Supplementary  Fig. 4i ). Both sEILP1s and sEILP2s gave rise to Mac-1 + DCs after culture for 10 d under SF7-GM3 and SF7-GM3-MG6 conditions; however, sEILP1-derived DC colonies were larger than sEILP2-derived DC colonies ( Supplementary Fig. 4j ,k), consistent with a larger proliferative capacity of more upstream progenitors 16 . These results indicate that sEILP1s transitioned through the sEILP2 stage before DC differentiation. To determine whether sEILPs differentiated into DCs in vivo at steady state, we analyzed Lin
hi sEILPs for CD11c expression (Fig. 4d) . This analysis identified a population of CD11c + cells phenotypically similar to sEILPs (CD11c + EILPs; Fig. 4d ). Expression of NRP-1 (Fig. 4d) , MHC-II and CCR2 proteins (Fig. 4e) was low on sEILP1s, intermediate on sEILP2s, and high on CD11c + EILPs. Tcf7-GFP was lower on CD11c + EILPs than on sEILP1s and sEILP2s, but clearly positive compared with pre-DCs (Fig. 4e) . Further characterization of CD11c + EILPs using surface markers described on pre-DC populations (CD24, CCR2, Ly-6D, Ly-6C and Siglec-H) 11, 12 showed that CD11c + EILPs were phenotypically similar to pre-cDC1s ( Supplementary Fig. 5c ).
To test whether CD11c + EILPs were derived from EILPs, we analyzed these cells in Il7r-iCre R26-stop-YFP mice crossed with Tcf7 EGFP mice. More than 80% of CD11c + EILPs were Il7r-iCre R26-stop-YFP + , similar to sEILPs (Fig. 4f) 1 . In contrast, only ~10% of canonical DC precursors (pre-cDC1 and pre-cDC2), and even fewer Lin − Kit hi upstream hematopoietic progenitor cells, were Il7r-iCre R26-stop-YFP + (Fig. 4f) . In Tox −/− mice, CD11c + EILP and sEILP absolute numbers were 3-4-fold reduced compared with Tox +/+ littermates ( Fig. 4g) 1 , whereas canonical DC precursors such as pre-cDC1s and pre-cDC2s were present in normal numbers (Fig. 4g) . These results indicate that CD11c + EILPs derive from EILPs. Although EILPs are tenfold less abundant than pre-cDC1 and pre-cDC2 (Fig. 4g) , we examined whether ILC progenitors contribute to DC generation in vivo. In Tcf7
+ cells represented <5% of pre-cDC1 in vivo, and were almost undetectable within other DC precursor populations (Supplementary Fig. 5e Fig. 5f ), suggesting that EILPs were unlikely to contribute significantly to DC development in vivo. Our results establish that EILPs generate cDC1 precursors in vivo at steady state, and support a linear developmental relationship linking sEILP1s, sEILP2s and the pre-cDC1 subset CD11c + EILPs.
TCF-1-deficient sEILPs do not generate cEILPs. Next, we investigated whether TCF-1 regulates the transition from sEILP1s to cEILPs. Deletion of exon 2 of Tcf7 and the surrounding floxed for n = 7 mice per group, pooled from three independent experiments. A two-tailed unpaired Student's t-test was performed to determine significance (**P < 0.01; ***P < 0.005). In a-d and f, numbers indicate the percentage of cells in each gate. All data are representative of three independent experiments. See Supplementary Fig. 5 for the definition of canonical DC precursors.
region in Tcf7
EGFP mice generated mice with a Tcf7 EGFPnull allele ( Supplementary Fig. 6a ), which were crossed to Tcf7 −/− mice to obtain Tcf7
EGFPnull/− mice. Tcf7 EGFPnull/− mice reported Tcf7 expression like Tcf7 EGFP mice, but lacked TCF-1 protein ( Supplementary  Fig. 6a-d) . Lin ILC−
Tcf7-GFP
+ cells were detectable in Tcf7
EGFPnull/− BM ( Supplementary Fig. 6e ) 2 and were α4β7 + 2B4 + ( Supplementary  Fig. 6f) .
Numbers of EILPs in Tcf7
EGFPnull/− mice were reduced twofold compared with wild-type mice (Fig. 5a) 
, and Tcf7
EGFPnull/− EILPs were Flt3 hi ( Supplementary Fig. 6f ), suggesting that ILC development was arrested at the sEILP stage. In the absence of TCF-1 protein, we used TOX expression to quantify the number of EILPs in Tcf7 −/− mice ( Supplementary Fig. 6g,h and Tcf7 +/+ BM ( Supplementary Fig. 6h) (Fig. 5b) or PU.1 (Fig. 5c) (Fig. 5d) , 
Tcf7
EGFPnull/+ cEILP ). A profile of the derived population is shown. h, Quantification of DC and ILC numbers, as in g. Data are presented as means ± s.d. for n = 3 triplicate wells. In a-d and g, numbers indicate the percentage of cells in each gate. In a-d, g and h, data are representative of three independent experiments. In a-d and h, a two-tailed unpaired Student's t-test was performed to determine significance (*P < 0.05; **P < 0.01). See also Supplementary Fig. 6 for a description of the Tcf7
EGFPnull mouse strain, and Supplementary Table 2 for additional RNA-Seq data.
confirming that TCF-1 was required cell-autonomously for the generation of cEILPs.
EGFPnull/− EILPs were transcriptionally similar to wild-type sEILPs (Fig. 5e) , consistent with developmental arrest of Tcf7
EGFPnull/− EILPs at the sEILP stage. Genes dynamically regulated between ALPs and sEILPs, such as Nfil3, Id2 and Tox, were similarly regulated between ALP and Tcf7
EGFPnull/− EILPs (Fig. 5f, Supplementary  Fig. 6i and Supplementary Table 2 ), indicating that early ILC lineage specification was largely unaffected by loss of TCF-1. Consistently, Tcf7
EGFPnull/− EILPs cultured for 4 d under SF7 conditions were still able to generate DCs (Fig. 5g,h ). These observations indicate that TCF-1 was dispensable for initial ILC specification, but was required for progression towards the ILC lineage.
TCF-1-deficient EILPs are diverted towards the DC lineage.
Although developmental arrest at the sEILP stage in TCF-1-deficient mice predicted a twofold higher frequency of DC-competent sEILPs in Tcf7
EGFPnull/− EILPs, Tcf7 EGFPnull/− EILPs cultured for 4 d under SF7 conditions gave rise to fewer DCs than wild-type EILPs (Fig. 5g,h) . Expression of Batf3 and Id2, which was higher on sEILP2s compared with sEILP1s (Fig. 1f) , was twofold higher on Tcf7
EGFPnull/− EILPs compared with wild-type sEILPs ( Fig. 5f and Supplementary Table 2 ), suggesting that a larger fraction of sEILPs might be primed towards the DC lineage in the absence of TCF-1. The number of NRP-1 − sEILP1s was similar, whereas the number of NRP-1 +
MHC-II
+ sEILP2s was increased twofold in Tcf7
EGFPnull/− mice compared with wild-type mice (Fig. 6a) . In single-cell assays, Tcf7 EGFPnull/− sEILPs generated fewer Mac-1 + DCs than wild-type sEILPs ( Supplementary Fig. 7a,b EGFPnull/− sEILP1s and n = 276 Tcf7 EGFPnull/− sEILP2s (black), and n = 615 Tcf7 EGFP/+ sEILP1s and n = 187 Tcf7 EGFP/+ sEILP2s (pink) from scRNA-Seq analysis. A two-sided Wilcoxon rank-sum test was used to determine the significance of gene expression differences between Tcf7
EGFPnull/− and Tcf7 EGFP/+ cells for a given subset (***P < 0.005). See also Supplementary Fig. 7 (Fig. 6b) . In t-distributed stochastic neighbor embedding (t-SNE) analysis, only ~5% Tcf7
EGFPnull/− cells overlapped with wild-type cEILPs, ILCPs or ILC2Ps (Fig. 6c) . Relative quantification of Tcf7
EGFPnull/− and Tcf7 EGFP/+ cells in each cluster showed that 51% of Tcf7
EGFPnull/− sEILPs corresponded to sEILP2, whereas only 23% of wild-type sEILPs were sEILP2s (Fig. 6d) . The transcription factors Irf8, Id2, Nfil3, Spi1 and Mef2c were upregulated, and Zbtb16 was downregulated in Tcf7
EGFPnull/− sEILP1s compared with wild-type sEILP1s (Fig. 6e and Supplementary Table 3 ). These altered expression patterns were most obvious for sEILP1s on the main progression ( Supplementary Fig. 7c,d ), suggesting that they preceded diversion towards the DC lineage ( Supplementary Fig. 7e and Supplementary Table 4 ). These observations indicate that, in the absence of TCF-1, sEILP1s adopted a cDC1 progenitor-like transcriptional profile and were diverted towards the DC fate. . Previously described enhancers are indicated by black boxes, along with their distance relative to the transcription start site 20, 21 . See also Supplementary Fig. 7 and Supplementary Tables 5-7.
TCF-1 enhances expression of ILC genes and represses DC genes.
To identify TCF-1 gene targets during ILC development, we first inferred regulatory interactions between genes using the lag-based expression association for pseudotime series (LEAP) algorithm 17 . We used the main progression to identify genes whose expression was correlated during ILC development, allowing a gap in correlation to take into account delays between the expression of a controller and its targets ( Supplementary Fig. 7f and Supplementary Table 5 ). To determine which of the putative TCF-1 target genes identified were directly regulated by TCF-1, we characterized TCF-1 binding in EILPs using chromatin immunocleavage sequencing (ChIC-Seq) 18 , and identified open chromatin regions in ALPs, EILPs and ILCPs using DNase I hypersensitive sites sequencing (DNase-Seq). We identified 9,649 TCF-1 peaks genome wide in EILPs (Supplementary Table 6 ). Of these, 99% were located in regions of open chromatin in ALPs (Fig. 7a and Supplementary  Fig. 7g ). Regions bound by TCF-1 showed significant enrichment for TCF motifs, as well as runt-related transcription factor (RUNX) and PU.1 motifs (Fig. 7b) .
To identify TCF-1 target genes, we identified genes predicted to be regulated by TCF-1 (Supplementary Table 5) , and showed TCF-1 binding in open chromatin regions in their vicinity (Supplementary Table 6 ). We excluded genes that were properly regulated in the absence of TCF-1 in scRNA-Seq or bulk RNASeq (Supplementary Tables 2 and 3 ). This analysis identified 59 genes that received direct regulatory inputs from TCF-1 in EILPs ( Fig. 7c and Supplementary Table 7 ). Downregulated genes were enriched for genes involved in myeloid cell differentiation (Fig. 7d) , some of which (Flt3, Nfil3, Mef2c, Spi1 and Irf8) were upregulated in Tcf7
EGFPnull/− sEILP1 cells in the main trajectory compared with wild-type sEILP1s ( Supplementary Fig. 7h and Supplementary  Table 4) , and were downregulated from sEILP1s to cEILPs in wildtype ILC progenitors (Fig. 1f) . In contrast, genes upregulated by TCF-1 were enriched for genes involved in lymphocyte differentiation and activation (Fig. 7d) , such as Id2 or Gata3, which play important functions in EILPs 1,4 ( Fig. 7c) , indicating that TCF-1 promoted ILC differentiation. Genes important at later stages of development and ILC maturation, such as Il7r, Ets1 or Pdcd1 (encoding PD-1) were also predicted TCF-1 targets (Fig. 7d) . A few genes predicted to be positively regulated by TCF-1 (Zbtb16, Ccl5 and Rora) were upregulated between ALPs and sEILP1s (Supplementary Table 1) and had lower expression in Tcf7
EGFPnull/− sEILP1s compared with wild-type sEILP1s ( Supplementary Fig. 7e,h) .
Comparison of TCF-1 binding in EILPs and T lineage cells 19 revealed that several TCF-1 binding regions were shared, including the downstream Gata3 enhancer important for early T cell development (Tce1) 20 and the Pdcd1 enhancer active in exhausted T cells 21 ( Fig. 7e) . TCF-1 contributes to the regulation of these enhancers in T cells 20, 21 , indicating that TCF-1 can regulate similar loci in T cells and ILCs. Additional genes expressed in both T cells and ILCs, such as Id2, Socs1, Sla2 and Txk had similar patterns of TCF-1 binding in both lineages, whereas other genes such as Irf8, Lmo2 and Flt3 showed distinct patterns (Fig. 7e) . Our analysis indicated that TCF-1 promoted ILC development by positively regulating ILCspecific genes, and enforced ILC commitment through the repression of genes shared by sEILP1s and DCs (Supplementary Fig. 7i ).
Discussion
In this study, we used population-level and minimally biased single-cell approaches to identify transcriptional and functional heterogeneity of ILC progenitor cells, and to understand developmental relationships between them. Our work confirmed a linear developmental path between ALPs, EILPs, ILCPs and ILC2Ps 1, 8 . We identified two successive stages of ILC development within EILPs, which we called sEILP1 and cEILP, and delineated a commitment checkpoint during early ILC development. We also identified a developmental bifurcation towards the DC fate at the sEILP1 stage at steady state in vivo. We further defined a role for the transcription factor TCF-1 in controlling these developmental transitions. We found that TCF-1 was dispensable for initial ILC specification and generation of sEILP1s, but required for the development of cEILPs. Mechanistically, TCF-1 enforced commitment to the ILC lineage by providing positive regulatory inputs to key ILC genes, and by repressing the expression of genes key for DC development that were expressed at the early steps of ILC specification and downregulated during ILC commitment.
Many genes bound and upregulated by TCF-1 during early ILC development also have important functions in T cells, which raises the possibility that TCF-1 regulates these genes in both lineages. Consistently, key enhancers described to receive regulatory inputs from TCF-1 in T cells, including the distal Gata3 and Pdcd1 enhancer, were bound by TCF-1 in ILC progenitors. We found that chromatin bound by TCF-1 in EILPs was almost entirely accessible in upstream ALPs. This finding indicates that TCF-1 binding is largely dictated by the regulatory landscape established before T cell and ILC specification, in precursors of these lineages. TCF-1 binding sites showed significant enrichment for binding motifs for RUNX and PU.1 transcription factors. Hence, RUNX1 and PU.1 may mediate chromatin opening to allow TCF-1 binding 22, 23 , or these factors may serve to recruit TCF-1 to its binding sites during T cell and ILC specification 24 . Our findings raise the possibility that TCF-1 regulates a shared set of core genes in T cells and ILCs, which coordinates the acquisition of functional similarities between the two lineages 1 . Although the observation that ILC progenitors had the ability to develop into DCs was similar to DC lineage potentials reported for other uncommitted lymphoid progenitors, such as early T cell precursors 25 and ALPs
26
, our study provides evidence that some lymphoid precursors actually fulfilled this potential in vivo at steady state, and that DC development occurred from non-canonical DC precursors. Because sEILPs and other lymphoid precursors do not appear to contribute significantly to DC generation, nor do they generate distinct lineages of DCs 27, 28 , such a pathway may not be important in physiological conditions. We speculate that the residual DC development described here is the result of the imprecision of molecular mechanisms that underly early lymphoid specification, and a consequence of the transcriptional similarities between EILPs and DC progenitors 10 . More generally, because of the complexity of specification mechanisms, other developmental processes may be similarly prone to imprecisions 29, 30 . In summary, our work revealed that EILPs are heterogeneous, and that innate cell lineage specification before commitment occurred with a degree of imprecision and co-opted transcriptional programs permissive for DC development. Our work revealed that a residual DC development accompanied early ILC specification in vivo, and identified mechanisms by which TCF-1 restrained this alternative potential and mediated commitment to the ILC lineage.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of code and data availability and associated accession codes are available at https://doi.org/10.1038/ s41590-019-0445-7. YFP mice were generated as follows. First, the targeting vector was generated by bacterial artificial chromosome (BAC) recombineering. To begin with, a 10,538-nucleotide-long mouse genomic Tcf7 fragment starting with ATGTATATATGTGCCCCTTCCT... and ending with ...CAGGGTTACAAAGCTGGGT was inserted into the BAC retrieval vector PL253 (NCI at Frederick) by BAC recombineering. Next, a synthetic DNA construct was designed. This started with ACACAAGATTCCTCTTG... of Tcf7 intron 9, followed by the beginning of exon 10, which was fused at the carboxy terminus of its ...FLPMTVL amino acid sequence to the P2A ribosomal skipping peptide. This was followed by the YFP sequence and the rest of Tcf7 exon 10, starting at TAGGCTGTCCCCGGTCCCCAGC..., and the synthetic construct ended with the Tcf7 sequence ...AGAAACTCTTTTTGCGCC. After synthesis (Blue Heron), this 2,251-nucleotide-long construct was inserted into the EcoRI and KpnI sites of PL452 (NCI at Frederick). In addition, a Tcf7 genomic arm of ~400 nucleotides, located upstream of the ...ACACAAGATTCCTCTTG sequence of intron 9 was cloned into the multiple cloning site of PL452 adjacent to its loxP site, resulting in a 'mini targeting vector' containing the P2A-YFP construct and both arms of homology. This 'mini vector' was recombined into the above pL253 Tcf7 genomic vector by a second round of BAC recombineering, resulting in the final targeting vector. This final plasmid contains, in this order, an upstream arm of 4,259 nucleotides, a 1,888-nucleotide-long floxed pgk neo cassette, the 218-nucleotide-long 3′ terminal end of Tcf7 intron 9, exon 10 with the P2A ribosomal skipping peptide inserted after the ...FLPMTVL sequence (a total of 310 nucleotides), the YFP sequence (720 nucleotides), the additional downstream part of exon 10 (1,159 nucleotides) and an additional 4,039-nucleotide intronic sequence (the total downstream arm is 5,198 nucleotides). C57Bl6N ES cells (strain EAP6; developed by T.R., J. Richa, K. Kaestner and E. Pierce as members of the Penn Knockout Mouse Project) were electroporated with this vector and selected by G418 (geneticin), and 196 resulting embryonic stem cell clones were screened by Southern blotting, resulting in several positive clones. After ascertaining the correct karyotype by chromosome counting, independent positive embryonic stem cell clones were injected into C57BL/6 blastocysts at the Penn Transgenic and Chimeric Mouse Facility, yielding 100% C57BL/6 background male chimeras, which were bred to B6 females. Tcf7 YFP mice are described in Supplementary Fig. 3 .
Methods
Mice
Tcf7
EGFPnull mice were generated by breeding the Tcf7 EGFP mice 4 with CMV-Cre mice, and are described in Supplementary Fig. 6 . The mice used were 6-10 weeks old and of either sex. Animal procedures were approved by the relevant National Institutes of Health (NIH) Animal Care and Use Committees. ) is a mix of the following antibodies: anti-B220, CD19, Thy1, Mac-1, Gr-1, Ter119, NK1.1, CD3ε, CD8α, CD8β, CD4, TCRβ and TCRγδ. TOX, PLZF, GATA-3, NFIL3, PU.1, IRF-8 and TCF-1 expression was detected by intracellular staining using eBioscience's transcription factor staining buffer set according to the manufacturer's instructions. The antibody C63D9 was used for TCF-1 detection unless specified otherwise. Live/dead discrimination was performed by staining with DAPI or LIVE/DEAD Fixable Blue (Invitrogen). Samples were acquired using an LSRFortessa flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star). All analyses are presented on singlet live cells as shown in Supplementary Fig. 1 . GFP/YFP separation was achieved using the filters 509/21, 505LP and 530/30, 525LP. BM progenitors were sorted using an Aria flow cytometer (BD Biosciences).
BM progenitor definition, isolation and culture. Unless specified otherwise, BM progenitors were defined and isolated by flow cytometric sort as follows. Fig. 4d . sEILP1s and sEILP2s were separated using NRP-1 and MHC-II expression on sEILPs, as shown in Fig. 4b . Canonical precursors were divided into subsets using previously described markers 33, 34 . Pre-DCs are defined as Lin
, and pre-cDCs are Siglec-H − pre-DCs ( Supplementary Fig. 5a ). Pre-cDCs can be further separated into Kit +
Ly-6C
− pre-cDC1s and Kit − Ly-6C + pre-cDC2s ( Supplementary  Fig. 5b ). BM progenitors were cultured on irradiated OP9 stromal layers in α-MEM media supplemented with 20% fetal bovine serum, glutamine, penicillin and streptomycin. All cultures were supplemented with stem cell factor, Flt3-L and IL-7 at 30 ng ml −1 (SF7 conditions). Granulocyte-macrophage colony-stimulating factor and IL-3 (10 ng ml −1 ) were added for SF7-GM3 cytokine conditions, and macrophage colony-stimulating factor, granulocyte colony-stimulating factor and IL-6 (10 ng ml −1 ) were additionally used for SF7-GM3-MG6 cytokine conditions. All cytokines were purchased from PeproTech. CD45.2 + cells were considered for analysis of hematopoietic progeny.
scRNA-Seq and analysis. B cells isolated from spleen were added to each of the scRNA-Seq samples as an internal control. scRNA-Seq libraries were prepared using Chromium Single Cell 3′ kits, according to the manufacturer's instructions (version 2 chemistry; 10x Genomics). The obtained libraries were sequenced with a NextSeq system (version 2 chemistry; Illumina). Primary analysis was performed with Cell Ranger version 2.0.1 software using the default parameters. Median numbers of unique molecular identifier (UMI) counts ranged between 2,894 and 5,309 per cell. Cells with low UMI counts were determined by the 10x Genomics Cell Ranger Algorithm (https://support.10xgenomics.com/singlecell-gene-expression/software/pipelines/latest/algorithms/overview). After estimating the maximum total UMI count (or m) as the 99th percentile of the top 3,000 barcodes, those whose UMI count exceeded m/10 were called cells. The data were normalized and scaled, and cell cycle scores and mitochondrial percentages were regressed using the Seurat package 35 . Seurat's PCAFast function was run and the first 13 principal components were used in subsequent analysis. Cells were clustered using Seurat's FindClusters function. To visualize the data, t-SNE plots were generated using Seurat's RunTSNE function. B cells spiked in all samples formed their own cluster and overlapped on the t-SNE plot, thus confirming the validity of the normalization across samples. Small contaminant populations were identified on the basis of signature gene expression of mature populations from BM 13 . Such cells formed their own clusters, and appeared distant from the main progenitor populations on t-SNE. B cells and contaminant cells that represented 5% of the data were electronically removed before subsequent analysis. Seurat's FindClusters function was used to cluster the remaining data using default perplexity. A range of resolutions were tested, and a resolution of 0.65 was selected to capture known ILC progenitor groups and new subgroups without adding subdivisions within relatively homogenous ALPs. Differentially expressed genes between clusters were identified using Seurat's FindMarkers function. Only genes showing expression in at least 10% of cells in one of the groups compared were considered. A two-sided Wilcoxon rank-sum test was used to determine significance. Genes significantly different between clusters are shown in Supplementary Table 1. Pseudotime reconstruction analysis was performed on the first five principal components using the TSCAN package 9 . Violin plots shown in the figures were made using Seurat's log-transformed normalized data. Correlation network analysis along the scRNA-Seq pseudotime was performed using the LEAP package applied to the most variable genes expressed by at least 10% of the cells (1,094 genes) 17 . A lag of one-third of the pseudotime was allowed between correlated genes. Correlations of ≥0.2 were considered for further analysis (false discovery rate: <5 × 10 -5 ) and are shown in Supplementary Table 5 . Network visualization was done using Cytoscape ( Supplementary Fig. 7f ) 36 . Additional analysis and visualization was done using R 37 .
Bulk RNA-Seq and analysis. RNA was extracted using an RNeasy Plus Micro Kit (Qiagen) according to the manufacturer's instructions. Quality control was performed by bioanalyzer (Agilent), and RNA samples with a RNA integrity number of >9 were subsequently used. Messenger RNA-Seq libraries were prepared using a SMARTer Ultra Low Input RNA Kit version 3 (Clontech) and Nextera XT DNA Library Preparation Kit (Illumina). Paired-end sequence reads of 126 base pairs were generated with a HiSeq 2500 sequencer (Illumina). The raw RNA-Seq FASTQ reads were aligned to the mouse genome (mm10) using STAR (STAR_2.5.2b) on two-pass mode with mouse gencode (release M12) gtf 38 . Genes were subsequently counted using Rsubread 39 , and further analyzed for gene expression changes and statistics using limma-voom 40 , with quantile normalization and batch correction using ComBat 41 . The gene and sample-specific normalization factors were then used to correct counts and to generate bigwig files. Visualization was done using R 37 .
DNase-Seq, ChIC-Seq and analysis. DNase-Seq. DNase-Seq assays were performed as described 42 . Briefly, 300 cells from each cell type were collected by fluorescence-activated cell sorting. Then, 0.3 U DNase I (04716728001; Roche) was added to each cell type and incubated at 37 °C for 5 min. Reactions were stopped by adding 80 μl of stop buffer (10 mM Tris-HCl (pH 7.5), 10 mM NaCl, 0.15% SDS and 10 mM EDTA) containing 1 μl of 20 mg ml −1 proteinase K. Samples were incubated at 55 °C overnight, and DNA was purified by phenol-chloroform extraction followed by precipitation with ethanol in the presence of 20 μg glycogen. DNA was further processed for library production.
Small cell number ChIC-Seq. ChIC-Seq was performed as described 18 . Cells were fixed by adding a 1:15 volume of 16% w/v formaldehyde solution (Thermo Fisher Scientific) and incubating at room temperature for 10 min. The reaction was terminated by adding a 1:10 volume of 1.25 M glycine and incubating on ice for 5 min. The fixed cells were washed with ice-cold phosphate buffered saline twice, and collected by centrifugation. Then, 1 ml RIPA buffer (10 mM Tris-Cl, 1 mM EDTA, 0.1% sodium deoxycholate, 0.2% sodium dodecyl sulfate and 1% Triton X-100) was added to each of the sorted 500 ALP, EILP and ILCP cells, and incubated at room temperature for 30 min. Cells were rinsed with 500 μl binding buffer (10 mM Tris-Cl, 1 mM EDTA, 150 mM sodium chloride and 0.1% Triton X-100) twice and resuspended in 50 μl binding buffer. To prepare anti-TCF-1-bound protein A-micrococcal nuclease (pA-MNase; antibody + PA-MNase), anti-TCF-1 (C46C7; Cell Signaling) and the PA-MNase at a molecular ratio of 1:2 were pre-incubated at 4 °C for 30 min in 50 μl binding buffer. TCF-1 + PA-MNase were added to 50 μl binding buffer-resuspended cells and incubated for 1 h at 4 °C with rotation. Cells were washed using 200 μl wash buffer (10 mM Tris-Cl, 1 mM EDTA, 150 mM sodium chloride, 0.1% w/v SDS, 0.1% w/v sodium deoxycholate and 1% v/v Triton X-100) three times and pelleted by centrifugation at 600g for 2 min. Next, cells were rinsed using 200 μl rinsing buffer (10 mM Tris-Cl, 10 mM sodium chloride and 0.1% v/v Triton X-100). The MNase digestion was initiated by resuspending the rinsed cells in 40 μl reaction solution buffer (10 mM Tris-Cl, 10 mM sodium chloride, 0.1% v/v Triton X-100 and 2 mM CaCl 2 ) and incubating at 37 °C for 3 min. The reaction was stopped by adding 80 μl stop buffer (20 mM Tris-Cl (pH 8.0), 10 mM ethylenedioxy-bis-(ethylenenitrilo)-tetraacetic acid, 20 mM sodium chloride and 0.2% w/v SDS) and 1 μl proteinase K (Sigma-Aldrich), then incubating at 65 °C overnight. DNA was purified using phenol-chloroform extraction and ethanol precipitation. The purified DNA was further processed for library production.
Library preparation. Libraries were prepared according to Illumina's instructions. Briefly, DNA was end-repaired using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (3′ to 5′ exo minus) and dATP to yield a protruding 3′-' A' base for ligation of Illumina's adapters, which have a single 'T' base overhang at the 3′ end. The ligation reaction was performed by adding 2 μM Illumina's adapters to each sample and incubating at room temperature for 1 h. After adapter ligation, DNA was PCR amplified with Illumina primers for 16 cycles, and library fragments from 180-300 base pairs were isolated from an agarose gel. The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on a Hi-Seq 3000 following the manufacturer's protocols.
Analysis. Sequencing reads were aligned against the mm9 reference genome using Bowtie 2 (ref. 43 ) with default parameters. Reads from technical replicates and biological replicates were combined for peak calling. Duplicated reads were removed from further analysis. TCF-1 peaks were called using MACS2 (ref. 44 ) with default parameters. Motif discovery (Fig. 7b) , peak file annotation (Supplementary Table 6 ) and additional analysis were done with HOMER (version 4.10.1) 22 .
Biological process enrichment and visualization was done with Metascape ( Fig. 7d ) 45 . Additional visualization was done using R 37 .
Statistics. Statistical analysis was performed on groups with limited variance using Excel or Prism. Differences between groups of mice or wells were determined by two-tailed unpaired Student's t-test. A Welsh correction was applied for groups of unequal s.d. P < 0.05 was considered significant. Sample sizes were empirically determined. No samples or animals were excluded from the analysis, and no randomization or blinding was used.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
The accession number for the raw data of the RNA-Seq is GSE113767. The accession number for the raw data of the DNase-Seq and ChIC-Seq is GSE128483. All other relevant data are available from the corresponding author on request.
